Evidence map›Paper›PMID 35884739›Full record

ArticleBrain sciences2022

The Efficacy and Safety of Deep Brain Stimulation of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens (ALIC/NAcc-DBS) for Treatment-Refractory Obsessive-Compulsive Disorder: Protocol of a Multicenter, Randomized, and Double-Blinded Study.

Tingting Xu, Yuan Gao, Bin Li, Jiaxin Jiang, Huirong Guo, Xianzhi Liu, Hongxing Huang, Yuqi Cheng, Hualin Yu, Jie Hu and 3 more

Abstract read
In one paragraph

Article in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Incidental resolution of pedophilia in a patient undergoing deep brain stimulation (DBS) for obsessive-compulsive disorder (OCD): a case report and long-term follow-up.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tingting XuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.ORCID 0000-0002-9704-7125
Yuan GaoWest China Hospital, Sichuan University, Chengdu 610041, China.
Bin LiWest China Hospital, Sichuan University, Chengdu 610041, China.
Jiaxin JiangWest China Hospital, Sichuan University, Chengdu 610041, China.
Huirong GuoThe First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China.
Xianzhi LiuThe First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China.
Hongxing HuangBrains Hospital of Hunan Province, Changsha 410015, China.
Yuqi ChengFirst Affiliated Hospital of Kunming Medical University, Kunming 650031, China.
Hualin YuFirst Affiliated Hospital of Kunming Medical University, Kunming 650031, China.
Jie HuHuashan Hospital, Fudan University, Shanghai 200040, China.
Xi WuChanghai Hospital, The Navy Military Medical University, Shanghai 200086, China.
Wei WangWest China Hospital, Sichuan University, Chengdu 610041, China.
Zhen WangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.ORCID 0000-0003-4319-5314

Funding

Shanghai Clinical Research Center for Mental Health 19MC1911100the Shanghai Science and Technology Committee 20XD1423100
6 · The paper itself

Abstract

backgroundsDeep brain stimulation (DBS) is an emerging and promising therapeutic approach for treatment-refractory obsessive-compulsive disorder (OCD). The most common DBS targets include the anterior limb of internal capsule (ALIC) and nucleus accumbens (NAcc). This protocol aims to explore the efficacy and safety of the combined ALIC- and NAcc-DBS for treatment-refractory OCD.

methodsWe will recruit 64 patients with refractory OCD from six centers, randomly allocate them to active and sham-stimulation groups through a three-month double-blind phase, then enter a three-month open-label phase. In the open-label stage, both groups experience real stimulation. OUTCOME MEASURES: The primary outcome will be the efficacy and safety of combined ALIC- and NAcc-DBS, determined by treatment response rate between the active and sham-stimulation groups at the double-blind stage and spontaneously reported adverse events. The secondary outcomes are comparisons of change in Y-BOCS, CGI, HAMD, and HAMA scores at the third and sixth months compared to baseline between the active and sham-control groups, as well as the scores of the third month minus the sixth month between the two groups.

Indexed as

anterior limb of internal capsuledeep brain stimulationnucleus accumbensobsessive-compulsive disorder

Identifiers

PMID35884739
PMCPMC9313119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.